Pioneers in Cold Laser Therapy
Established in 1990, MicroLight Corporation of America is a pioneer in cold laser therapy as the first company with FDA clearance to market low-level laser therapy (LLLT) for the non-surgical treatment of pain through adjunctive therapy in patients with Carpal Tunnel Syndrome.
The MicroLight 830 nanometer (nm) wavelength Gallium-Aluminum-Arsenide (GaAIAs) laser is classified by the FDA as a laser device for adjunctive use in pain therapy. There are 30+ years of clinical studies published on PubMed documenting that the 830nm range is the optimal wavelength to treat pain and inflammation.
Clinicians, therapists, dentists, veterinarians, and more have relied on the unique science of the MicroLight technology to treat their patients and themselves for more than 20 years.